On-site pathology improves the inadequacy rate of ultrasound-guided thyroid biopsies

May 05, 2010

Having a pathologist on-site during ultrasound-guided thyroid biopsies can decrease the number of repeat biopsies that are often performed due to an inadequate sample from the first procedure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

"Requests for ultrasound-guided biopsies for the diagnosis of have increased rapidly in recent years, putting a strain on radiology departments everywhere," said Wui K. Chong, MD, lead author of the study. Unfortunately, there are a number of inadequate biopsies (where the pathologist deems there is an insufficient amount of information to make a diagnosis) that ultimately must be repeated.

"Repeat is unpleasant and inconvenient for the patient and is obviously wasteful. Having a pathologist on-site to review the specimen can cut down on the number of patients returning for repeat biopsy, thus making more efficient use of resources," said Chong.

The study, performed at the University of North Carolina in Chapel Hill, NC, compared 200 biopsies that were performed with a pathologist on-site and 200 that were not. "We found that all other factors being equal, 13.5 percent of biopsies performed without a pathologist on-site were inadequate, compared to only 5 percent that were performed with a pathologist on-site," said Chong.

"As a result of this study, we recommend that radiologists performing large numbers of biopsies use on-site as it may reduce the need for repeat biopsy by up to 60 percent," he said.

Explore further: Phase 3 study may be game-changer for acute myeloid leukemia

Provided by American College of Radiology

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Bleeding risk associated with image-guided biopsies is low

Feb 19, 2010

Even among patients who have taken aspirin in proximity to an image-guided percutaneous biopsy, risk of major bleeding associated with the procedure is low, according to a study in the March issue of the American Journal of ...

Recommended for you

Phase 3 study may be game-changer for acute myeloid leukemia

2 hours ago

Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine ...

User comments : 0

More news stories

Fresh hope for preventing pneumonia in the elderly

There are calls for the frail and elderly not be be overlooked for vaccines against pneumonia this winter, with UNSW research challenging conventional wisdom on immunisation effectiveness in older patients.

Phase transiting to a new quantum universe

(Phys.org) —Recent insight and discovery of a new class of quantum transition opens the way for a whole new subfield of materials physics and quantum technologies.

Imaging turns a corner

(Phys.org) —Scientists have developed a new microscope which enables a dramatically improved view of biological cells.

NASA image: Volcanoes in Guatemala

This photo of volcanoes in Guatemala was taken from NASA's C-20A aircraft during a four-week Earth science radar imaging mission deployment over Central and South America. The conical volcano in the center ...

When things get glassy, molecules go fractal

Colorful church windows, beads on a necklace and many of our favorite plastics share something in common—they all belong to a state of matter known as glasses. School children learn the difference between ...